Enveric Biosciences

-$0.14 (-5.98%) Today
+$0.04 (+1.82%) As of 8:08 AM UTC after-hours

Why Robinhood?

You can buy or sell ENVB and other stocks, options, and ETFs commission-free!

About ENVB

Enveric Biosciences, Inc. Common Stock, also called Enveric Biosciences, is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments.

CEO
David Ian Johnson
Employees
3
Headquarters
Naples, Florida
Founded
1994

ENVB Key Statistics

Market Cap
49.99M
Price-Earnings Ratio
Dividend Yield
Average Volume
992.18K
High Today
$2.35
Low Today
$2.19
Open Price
$2.33
Volume
607.06K
52 Week High
$21.20
52 Week Low
$2.11

ENVB Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 14, Pre-Market

You May Also Like

CTRN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure